Day 3 | The session continued with talks on cardiovascular and immune phenotyping across fatiguing syndromes, Long COVID measurement gaps, post-infectious disease clinics and research, and clinical approaches to treatment.
#BREMC15#IIMEC18@Invest_in_ME#MECFS#Immunology
Day 3 | Therapeutics and Clinical Trials
The session continued with talks by Eva Untersmayr-Elsenhuber on emerging research into ME mechanisms, and Rowan Gardner on mechanistic insights from DecodeME population analyses.
#BREMC15#IIMEC18 @InvestinMEResearch #MECFS#Immunology
Day 3 | Continuing the session with data standardisation and sharing, updates from a multinational Long COVID treatment trial, and specialised care for seriously and very seriously ill people with ME.
#BREMC15#IIMEC18@Invest_in_ME#MECFS#Immunology
Day 3 | Continuing the session with data standardisation and sharing, updates from a multinational Long COVID treatment trial, and specialised care for seriously and very seriously ill people with ME.
#BREMC15#IIMEC18@Invest_in_ME#MECFS#Immunology
Day 3 | Session: Therapeutics and Clinical Trials, chaired by Andrew Wilson.
Exploring clinical trial platforms, brain fog treatment, hypoxia-induced mitochondrial stress signalling, wearable data, and data sharing in ME/CFS research.
@Invest_in_ME#BREMC15#IIMEC18#MECFS
Day 2 | Session 4, chaired by Jonas Bergquist.
Exploring autonomic dysfunction, oxidative stress, 3D chromatin architecture, the gut–microbiome–brain axis, PEM mechanisms, and GLP-1s in ME/CFS and Long COVID.
@Invest_in_ME#BREMC15#MECFS#Immunology
Day 2 | Keynote: Mapping the Human Body One Cell at a Time, by Sarah Teichmann.
Exploring how single-cell biology is transforming our understanding of human health, disease, and the cellular architecture of the body.
#BREMC15 @InvestinMEResearch #MECFS#Immunology
Day 2 | Session 2, chaired by Rikke Olsen.
Exploring mitochondrial energy metabolism, the itaconate shunt hypothesis, and failures in peripheral oxygen transport in ME/CFS.
@Invest_in_ME @InvestinMEResearch #MECFS#Immunology
Day 2 | Session 1: The Immune System, chaired by Eva Untersmayr-Elsenhuber.
Exploring innate immunity, post-infectious immune dysregulation, ion channel function, and tissue-specific immune responses in ME/CFS and Long COVID.
#BREMC15 @InvestinMEResearch #MECFS#Immunology
Day 1 | Session 4: Nervous System and Neuroinflammation, chaired by Jon Brooks.
Exploring neuroimaging, neuroinflammation and the brain's response to ME/CFS and post-COVID conditions.
#BREMC15 @InvestinMEResearch #MECFS#Neuroinflammation
Day 1 | Session 3: Chronic infection aetiology, chaired by Friðbjörn Sigurðsson.
Exploring persistent infection, immune dysregulation and post-viral syndromes in ME/CFS, from multiple international research perspectives.
#BREMC15 @InvestinMEResearch #MECFS#LongCOVID
Day 1 | Session 2: Genomics, chaired by Elisa Oltra.
Exploring T cell dysregulation in ME, genetic variants shared between Long COVID and ME/CFS, and precision medicine approaches to patient stratification.
#BREMC15 @InvestinMEResearch #MECFS#Genomics
Day 1, Session 1 of #BREMC15 explores Systems Biology & AI in ME/CFS research, chaired by @TamasKorcsmaros, with talks from Dezso Modos, Veronika Kedlian & Marek Ostaszewski.
Advancing data-driven biomedical research in #MECFS. @Invest_in_ME
The YE Symposium 2026 concluded last night with a pleasant boat trip on the River Cam.
Thank you to all the participants for making these two days so inspiring. We hope to see many of you again at our next meeting in Valencia, Spain, this fall.
#MECFS#Research#YoungEMERG
We concluded with the session “Finding Treatments for ME/CFS” with Prof. Andrew Wilson presenting his talk“Understanding Platform Trials and Their Potential for ME/CFS”, followed by Sophia Cameron-Christie “Boffins to Bedside: R&D in the Pharma Industry”
#MECFS#YoungEMERG
This morning, an excellent Poster Session was presented by the ECRs attending the Symposium 2026! ✨
A great opportunity to showcase ongoing projects and brand new ideas!
Who will take home the prize for Best Poster? 🏆
#MECFS#BiomedicalResearch#YoungEMERG@Invest_in_ME
Another insightful contribution to the session “Sampling Shapes Science: Recruitment Pathways Compared” from Dr Nancy Klimas:
“Who Gets In, Who Stays In, Who Gets Left Out: ME/CFS Design and Recruitment Strategies That Work” #MECFS#ClinicalResearch#YoungEMERG@Invest_in_ME
The session “Sampling Shapes Science: Recruitment Pathways Compared” continued with an engaging talk by Dr Jennifer Ahn-Jarvis:
“Recruitment Roadmap: Strategies for Recruiting Participants at the Quadram Institute”
#MECFS#ClinicalResearch#YoungEMERG@Invest_in_ME
The session “Sampling Shapes Science: Recruitment Pathways Compared” opened with an insightful talk by Dr Sankalpa Neupane:
“Inclusion & Exclusion Criteria in Clinical Trial Protocols: Key Considerations and Discussions”
#MECFS#ClinicalResearch#YoungEMERG